Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins attending: addendum: patient was scheduled to be discharged on friday , but did not leave secondary to weather conditions and no available ambulance. she remained at over the weekend without any changes in her status. she will be discharged today, with iv vancomycin for 7 days via picc line and no other antibiotics. the other change in her meds is patient no longer needs coumadin. patient will need void trial once at rehab and return to 2 for wound check on friday . chief complaint: see previous d/c note major surgical or invasive procedure: see previous d/c note history of present illness: see previous d/c note past medical history: see previous d/c note social history: see previous d/c note family history: see previous d/c note physical exam: see previous d/c note pertinent results: 04:31am blood wbc-9.1 rbc-3.55* hgb-10.1* hct-31.1* mcv-88 mch-28.4 mchc-32.5 rdw-17.5* plt ct-386 04:31am blood pt-19.9* inr(pt)-2.8 04:31am blood glucose-118* urean-11 creat-1.8* na-143 k-3.7 cl-105 hco3-24 angap-18 brief hospital course: see previous d/c note medications on admission: see previous d/c note discharge medications: 1. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). 2. levothyroxine sodium 50 mcg tablet sig: one (1) tablet po daily (daily). 3. amlodipine 5 mg tablet sig: two (2) tablet po daily (daily). 4. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 5. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 6. calcium acetate 667 mg tablet sig: one (1) tablet po tid w/meals (3 times a day with meals). 7. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 8. atorvastatin 10 mg tablet sig: one (1) tablet po daily (daily). 9. glipizide 5 mg tab, sust release osmotic push sig: one (1) tab, sust release osmotic push po daily (daily). 10. hydralazine 25 mg tablet sig: three (3) tablet po q6h (every 6 hours). 11. procanbid 500 mg tablet sustained release 12hr sig: 1.5 tablet sustained release 12hrs po twice a day. 12. vancomycin in dextrose 1 g/200 ml piggyback sig: one (1) intravenous q48h (every 48 hours) for 7 days. discharge disposition: extended care facility: bay - discharge diagnosis: coronary artery disease s/p coronary artery bypass grafting postoperative mesenteric ischemia postoperative hepatic failure/shock liver postoperative atrial fibrillation postoperative acute renal failure lower leg cellulitis diabetes mellitus hypertension hyperlipidemia hypothyroidism gastroesophageal refulx disease diabetic neuropathy obesity osteoarthritis discharge condition: good discharge instructions: patient may shower, no baths. no creams, lotions or ointments to incisions. no driving for at least one month. no lifting more than 10 lbs for at least 10 weeks from the date of surgery. local wound care and monitor wounds for signs of infection. patient needs to elevate legs and wear compression stockings. please call with any concerns or questions. followup instructions: dr. in 4 weeks dr. - call office for appt prior to discharge from rehab (1-2 weeks). clinic on , friday dr. - call office for appt prior to discharge from rehab (2-3 weeks). transplant surgery, dr. - appt on @ 3pm at transplant center in md procedure: venous catheterization, not elsewhere classified continuous invasive mechanical ventilation for 96 consecutive hours or more single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery enteral infusion of concentrated nutritional substances hemodialysis (aorto)coronary bypass of four or more coronary arteries other electric countershock of heart closed (percutaneous) [needle] biopsy of liver venous catheterization for renal dialysis cholecystectomy pulmonary artery wedge monitoring transfusion of packed cells biopsy of peritoneum injection or infusion of nesiritide infusion of vasopressor agent diagnoses: acidosis hyperpotassemia coronary atherosclerosis of native coronary artery intermediate coronary syndrome acute kidney failure with lesion of tubular necrosis congestive heart failure, unspecified unspecified essential hypertension acute and subacute necrosis of liver unspecified acquired hypothyroidism atrial fibrillation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes other and unspecified hyperlipidemia hypotension, unspecified other shock without mention of trauma cellulitis and abscess of leg, except foot obesity, unspecified systemic inflammatory response syndrome due to noninfectious process with acute organ dysfunction chronic cholecystitis 

Answer: The patient is high likely exposed to